32 completed, 15 unknown, 13 recruiting, 6 terminated. 14 Not applicable, 12 Phase 3, 11 Phase 4, 2 Phase 1, 2 Phase 2.
Follow Anticoagulants: new trials by email Literature Review of Anticoagulants trials Research Report on Anticoagulants
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices - Pulmonary Embolism, Venous Thromboembolism | Not yet recruiting | Nanjing First Hospital, Nanjing Medical University | 1300 | 2026-06-01 | 2026-05-22 | |
| Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis batroxobin, Anticoagulation Agents - Cerebral Venous Thrombosis | Phase 4 | Recruiting | Xuanwu Hospital, Beijing | 72 | 2026-01-30 | 2026-01-20 |
| Effect of Apiban Therapy on AVF Maturation in ESRD Patients Apixaban - Endstage Renal Disease, Direct Oral Anticoagulants (DOACs) | Not applicable | Recruiting | Combined military hospital lahore | 190 | 2026-01-01 | 2026-05-07 |
| Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation Antiplatelet or Anticoagulant Drugs - Oral Antiplatele, Anticoagulant Drugs | Not yet recruiting | Chengdu University of Traditional Chinese Medicine | 40 | 2025-10-01 | 2025-10-06 | |
| Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation discontinue anticoagulation therapy, Anticoagulant drugs, Catheter Ablation - Atrial Fibrillation (AF) | Early Phase 1 | Recruiting | China National Center for Cardiovascular Diseases | 3160 | 2025-08-05 | 2026-06-04 |
| Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) Anticoagulant Oral - Atrium; Fibrillation, Chronic Kidney Diseases | Phase 4 | Recruiting | Hospital Sirio-Libanes | 1500 | 2024-12-18 | 2025-02-21 |
| Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2) Anticoagulation Agents - Atrial Fibrillation, Peritoneal Dialysis Complication | Phase 3 | Not yet recruiting | University Hospital, Caen | 178 | 2024-10-30 | 2024-08-09 |
| The Gynecological Cancer Associated Thrombosis (GynCAT) Study Anticoagulant - Cancer-associated Thrombosis, Venous Thromboembolism | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1800 | 2024-04-15 | 2024-09-19 | |
| The PEERLESS II Study FlowTriever System, Anticoagulation Agents - Pulmonary Embolism | Not applicable | Active not recruiting | Inari Medical | 1200 | 2023-11-17 | 2026-10-08 |
| Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis Anticoagulant Oral, Anticoagulation combined with antiplatelet therapy - Acute Ischemic Stroke, Atrial Fibrillation | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2171 | 2023-09-29 | 2024-03-18 |
| Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF Anticoagulation Agents - Acute Ischemic Stroke, Atrial Fibrillation | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2351 | 2023-09-15 | 2024-03-18 |
| Anticoagulant-associated Intracranial Hemorrhage Anticoagulant - Anticoagulant-induced Bleeding, Intracranial Hemorrhages | Unknown | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 1200 | 2023-08-09 | 2023-12-13 | |
| A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF Oral anticoagulant - Atrial Fibrillation, Stroke | Phase 4 | Completed | Cedars-Sinai Medical Center | 14 | 2023-03-13 | 2026-08-10 |
| Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD anticoagulant or antiplatelet drugs - Anticoagulant Drugs, Antiplatelet Drug | Unknown | First Affiliated Hospital of Zhejiang University | 6000 | 2023-01-01 | 2023-05-10 | |
| ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE) Recombinant Human Prourokinase for Injection (rhPro-UK), standard medical treatment - Ischemic Stroke, Mild | Phase 3 | Completed | Beijing Tiantan Hospital | 1446 | 2022-11-15 | 2024-09-05 |
| Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic echocardiography - Myocardial Infarction Type 2 | Not applicable | Completed | University of Edinburgh | 60 | 2022-11-14 | 2024-09-19 |
| Carotid Web and Stroke Registry. Antiplatelet Drug, Anticoagulant, Endovascular - Stroke, Carotid Web | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 100 | 2022-07-15 | 2022-08-01 | |
| Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation Oral anticoagulant - Atrial Fibrillation, Obesity | Unknown | Ajou University School of Medicine | 56272 | 2022-01-01 | 2023-07-27 | |
| Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting Rivaroxaban, Aspirin - Deep Vein Thrombosis, Iliac Vein Thrombosis | Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | 172 | 2021-11-03 | 2025-09-25 |
| Restarting Anticoagulation After Traumatic Intracranial Hemorrhage Anticoagulants - Hemorrhage, Intracranial Hemorrhages | Phase 3 | Not yet recruiting | University of Texas at Austin | 1100 | 2021-10-01 | 2021-05-19 |
Showing 20 of 73. Sign in to see all of them.
Atrial Fibrillation (23) · Stroke (12) · Ischemic Stroke (8) · Thrombosis (6) · Venous Thromboembolism (6) · Hemorrhage (5) · Pulmonary Embolism (5) · Venous Thrombosis (5) · Coronary Artery Disease (4) · COVID-19 (3) · Hemostatic Disorders (3) · Myocardial Infarction (3) · Acute Coronary Syndrome (2) · Blood Coagulation Disorders (2) · Cardiovascular Diseases (2)
Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · The Medicines Company (3) · Assiut University (2) · Bayer (2) · First Affiliated Hospital of Zhejiang University (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) · Icahn School of Medicine at Mount Sinai (2) · Inari Medical (2) · National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (2) · Xuanwu Hospital, Beijing (2) · A.O.U. Città della Salute e della Scienza (1) · ARCA Biopharma, Inc. (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ajou University School of Medicine (1)
United States (17) · China (10) · Italy (8) · United Kingdom (6) · Brazil (4) · France (4) · Germany (4) · Spain (4) · Canada (3) · Egypt (3) · Japan (3) · Russia (3) · South Korea (3) · Belgium (2) · Netherlands (2)
Elizaveta Panchenko, PhD (2) · Ahmed M Abdul Ghani, MD (1) · Amanda Conti, MD (1) · Andrew Chapman, MBChB PhD (1) · Annetine C Gelijns, PhD (1) · Bernard Boneu, MD (1) · Bernhard Gebauer, MD (1) · Bruna Gigante, MD PhD (1) · Catalin Toma, MD (1) · Christine A McKiernan, MD (1) · Chuan Qin, Dr. (1) · Claudia Vanessa Cano Nigenda, MD (1)
PMID 17124018, PMID 17299194, PMID 17368152, PMID 18056903, PMID 19022155, PMID 19171852, PMID 19229428, PMID 19250106, PMID 19298914, PMID 19427958, PMID 19460609, PMID 19463378, PMID 19628125, PMID 19717844, PMID 20006130, PMID 20026777, PMID 20118151, PMID 20142447, PMID 20647564, PMID 20837828, PMID 20953817, PMID 20965465, PMID 21207349, PMID 21315212, PMID 21551462, PMID 21658558, PMID 21785475, PMID 21927046, PMID 22028471, PMID 22127656, PMID 22315271, PMID 22354934, PMID 22424026, PMID 22483327, PMID 22550156, PMID 23048052, PMID 23174632, PMID 23174634, PMID 23271794, PMID 23407628, PMID 23415013, PMID 23524219, PMID 24012035, PMID 24029542, PMID 24310521, PMID 24560063, PMID 24561145, PMID 24630881, PMID 24847016, PMID 25022226
2023 (1), U01HL088942 (1), UL1TR001082 (1)